Mankind Pharma will finalise the allocation of shares May 3, 2023. New Delhi: The initial share-sale of drug maker Mankind Pharma, that...
IPO Mankind Pharma: Investors in the Mankind Pharma IPO can check their share allotment status. Read More:– India’s Growth Story Continues: NITI Aayog...
Mankind Pharma IPO: Today is the last day to apply for the public issue worth Rs 4,326.36 crore; Should you Buy? Mankind...
Mankind Pharma IPO Day 1: A bidder will be able to apply in lots and one lot of the IPO will comprise...
Mankind Pharma claimed to be India’s fourth-largest pharmaceutical company in terms of domestic sales and third-largest in terms of sales volume Read...
The three-day initial public offering (IPO) of Delhi-based drug maker Mankind Pharma will open for public subscription on 25 April and close...
Mankind Pharma IPO is entirely an offer for sale (OFS) of 40,058,844 equity shares by promoters and other existing shareholders. Mankind Pharma’s...
Upcoming IPOs: Several companies have already filed their Draft Red Herring Prospectus (DRHP) Upcoming IPOs: The two-month drought in the IPO market is set...
PE firm ChrysCapital-backed Mankind Pharma, the maker of top-selling condom brand Manforce Condoms, has filed its DRHP with SEBI PE firm ChrysCapital-backed...
Panacea Biotec Pharma is a subsidiary of vaccine maker Panacea Biotec; its domestic biz had a turnover of Rs 219 cr in...